Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cecily J Forsyth

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Perfusion|June 14, 2022
Paraprotein associated heparin resistance during cardiopulmonary bypassJacqueline N Khuong, Cecily J Forsyth, Lucy Manuel, et al.
Leukemia & Lymphoma|June 29, 2012
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaJane A Freeman, Kyle R Crassini, O Giles Best, et al.
Internal Medicine Journal|November 10, 2018
Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasmsCecily J Forsyth, Wai-Hoong Chan, Andrew P Grigg, et al.
British Journal of Haematology|February 23, 2018
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaKyle R Crassini, Eva Zhang, Shalini Balendran, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2013
A multicenter, open-label, noncomparative screening study of enzastaurin in adult patients with non-Hodgkin lymphomasCecily J Forsyth, David Gomez-Almaguer, Johnny F C Camargo, et al.
Blood|December 19, 2014
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsDavid T Yeung, Michael P Osborn, Deborah L White, et al.
Ejhaem|August 19, 2024
Variation in immunoglobulin use and impact on survival in myelomaKhai Li Chai, Cameron Wellard, Ltp Thao, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Perfusion|June 14, 2022
Paraprotein associated heparin resistance during cardiopulmonary bypassJacqueline N Khuong, Cecily J Forsyth, Lucy Manuel, et al.
Leukemia & Lymphoma|June 29, 2012
Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaJane A Freeman, Kyle R Crassini, O Giles Best, et al.
Internal Medicine Journal|November 10, 2018
Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasmsCecily J Forsyth, Wai-Hoong Chan, Andrew P Grigg, et al.
British Journal of Haematology|February 23, 2018
Humoral immune failure defined by immunoglobulin class and immunoglobulin G subclass deficiency is associated with shorter treatment-free and overall survival in Chronic Lymphocytic LeukaemiaKyle R Crassini, Eva Zhang, Shalini Balendran, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 18, 2013
A multicenter, open-label, noncomparative screening study of enzastaurin in adult patients with non-Hodgkin lymphomasCecily J Forsyth, David Gomez-Almaguer, Johnny F C Camargo, et al.
Blood|December 19, 2014
TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsDavid T Yeung, Michael P Osborn, Deborah L White, et al.
Ejhaem|August 19, 2024
Variation in immunoglobulin use and impact on survival in myelomaKhai Li Chai, Cameron Wellard, Ltp Thao, et al.
Pageof 1